<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Physiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id><journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id><journal-title-group><journal-title>Frontiers in Physiology</journal-title></journal-title-group><issn pub-type="epub">1664-042X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6052911</article-id><article-id pub-id-type="doi">10.3389/fphys.2018.00865</article-id><article-categories><subj-group subj-group-type="heading"><subject>Physiology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Reactive Oxygen Species and Pulmonary Vasculature During Hypobaric Hypoxia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Siques</surname><given-names>Patricia</given-names></name><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/456672/overview"/></contrib><contrib contrib-type="author"><name><surname>Brito</surname><given-names>Julio</given-names></name><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/456675/overview"/></contrib><contrib contrib-type="author"><name><surname>Pena</surname><given-names>Eduardo</given-names></name><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/491268/overview"/></contrib></contrib-group><aff><institution>Institute of Health Studies, Arturo Prat University</institution>, <addr-line>Iquique</addr-line>, <country>Chile</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Cristina M. Sena, University of Coimbra, Portugal</p></fn><fn fn-type="edited-by"><p>Reviewed by: Wang Min, Yale University, United States; Marcos Lopez, Fundaci&#x000f3;n Cardiovascular de Colombia, Colombia</p></fn><corresp id="c001">*Correspondence: Patricia Siques, <email>psiques@tie.cl</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Oxidant Physiology, a section of the journal Frontiers in Physiology</p></fn></author-notes><pub-date pub-type="epub"><day>09</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>865</elocation-id><history><date date-type="received"><day>18</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>18</day><month>6</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Siques, Brito and Pena.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Siques, Brito and Pena</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>An increasing number of people are living or working at high altitudes (hypobaric hypoxia) and therefore suffering several physiological, biochemical, and molecular changes. Pulmonary vasculature is one of the main and first responses to hypoxia. These responses imply hypoxic pulmonary vasoconstriction (HPV), remodeling, and eventually pulmonary hypertension (PH). These events occur according to the type and extension of the exposure. There is also increasing evidence that these changes in the pulmonary vascular bed could be mainly attributed to a homeostatic imbalance as a result of increased levels of reactive oxygen species (ROS). The increase in ROS production during hypobaric hypoxia has been attributed to an enhanced activity and expression of nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase), though there is some dispute about which subunit is involved. This enzymatic complex may be directly induced by hypoxia-inducible factor-1&#x003b1; (HIF-1&#x003b1;). ROS has been found to be related to several pathways, cells, enzymes, and molecules in hypoxic pulmonary vasculature responses, from HPV to inflammation, and structural changes, such as remodeling and, ultimately, PH. Therefore, we performed a comprehensive review of the current evidence on the role of ROS in the development of pulmonary vasculature changes under hypoxic conditions, with a focus on hypobaric hypoxia. This review provides information supporting the role of oxidative stress (mainly ROS) in the pulmonary vasculature&#x02019;s responses under hypobaric hypoxia and depicting possible future therapeutics or research targets. NADPH oxidase-produced oxidative stress is highlighted as a major source of ROS. Moreover, new molecules, such as asymmetric dimethylarginine, and critical inflammatory cells as fibroblasts, could be also involved. Several controversies remain regarding the role of ROS and the mechanisms involved in hypoxic responses that need to be elucidated.</p></abstract><kwd-group><kwd>reactive oxygen species</kwd><kwd>pulmonary hypertension</kwd><kwd>hypobaric hypoxia</kwd><kwd>NADPH oxidase</kwd><kwd>pulmonary vasculature</kwd></kwd-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="105"/><page-count count="9"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p>There are two main sources or conditions of hypoxia to which humans are exposed: normobaric hypoxia (at sea level) and hypobaric hypoxia (at high altitudes). Exposure to hypobaric hypoxia can be classified as acute, chronic hypoxia (CH) or chronic intermittent hypoxia (CIH) exposure (<xref rid="B63" ref-type="bibr">Richalet et al., 2002</xref>). High-altitude or hypobaric hypoxia exposure leads to a reduction in arterial oxygen saturation due to a drop in the partial pressure of oxygen (PaO<sub>2</sub>), triggering several physiological and/or pathological effects, with pulmonary vascular system changes being among the most important effects (<xref rid="B35" ref-type="bibr">Jensen et al., 1992</xref>; <xref rid="B55" ref-type="bibr">Moudgil et al., 2005</xref>; <xref rid="B14" ref-type="bibr">Brito et al., 2007</xref>). These changes are dependent on exposure time and altitude (<xref rid="B68" ref-type="bibr">Scherrer et al., 2013</xref>).</p><p>In the clinic, the most well-known CIH is obstructive sleep apnea (OSA), with a prevalence of approximately 14% of the general population. In this condition, the hypoxic state is intermittently maintained for brief periods (<xref rid="B21" ref-type="bibr">Dumitrascu et al., 2013</xref>). Although less common, a large body of literature is available on hypobaric hypoxia, which results from living at or ascending to a high altitude. Acute exposure typically applies to tourists and recreational climbers, whereas CH exposure applies to people permanently living at high altitude. Both conditions and their related diseases are rather well characterized (<xref rid="B40" ref-type="bibr">Le&#x000f3;n-Velarde et al., 2005</xref>). Over 100 million people are estimated to live at high altitude (<xref rid="B56" ref-type="bibr">Niermeyer et al., 1995</xref>; <xref rid="B54" ref-type="bibr">Moore, 2001</xref>).</p><p>A new model of CIH has been described after the development of mine settlements at high altitudes (over 3000 masl), although this model of hypobaric hypoxia is completely different from other types of intermittent hypoxia such as OSA (<xref rid="B63" ref-type="bibr">Richalet et al., 2002</xref>). This type of exposure affects workers commuting to work at high altitude for several days and then resting at sea level for the same period over several years (<xref rid="B63" ref-type="bibr">Richalet et al., 2002</xref>). This condition is rather new, and few research studies on the subject are available. Despite some similarities, the changes and mechanisms involved may not be applicable to all types of intermittent hypoxia.</p><p>The first vasculature pulmonary phenomenon is hypoxic pulmonary vasoconstriction (HPV) in response to alveolar oxygen pressure. This intrinsic mechanism in the lungs optimizes systemic oxygen delivery by matching perfusion to ventilation (<xref rid="B87" ref-type="bibr">Von Euler and Liljestrand, 1946</xref>; <xref rid="B19" ref-type="bibr">Desireddi et al., 2010</xref>; <xref rid="B22" ref-type="bibr">Dunham-Snary et al., 2017</xref>). This vasoconstrictor effect is modulated by vasoactive substances present in the blood or released from the endothelium and lung parenchyma and can vary with age and species (<xref rid="B39" ref-type="bibr">Leblanc et al., 2013</xref>). In contrast, in the systemic vasculature, hypoxia causes a vasodilator effect through the ATP-dependent potassium channel, leading to the relaxation of smooth muscle cells (SMCs) (<xref rid="B92" ref-type="bibr">Weir and Archer, 1995</xref>). When alveolar hypoxia is sustained over time, as in CH or in patients with chronic lung disease, HPV can contribute to initiating vascular remodeling and the subsequent development of pulmonary hypertension (PH) and, ultimately, heart failure (<xref rid="B60" ref-type="bibr">Pe&#x000f1;aloza et al., 1971</xref>; <xref rid="B103" ref-type="bibr">Xu and Jing, 2009</xref>; <xref rid="B41" ref-type="bibr">Le&#x000f3;n-Velarde et al., 2010</xref>; <xref rid="B64" ref-type="bibr">Rimoldi et al., 2012</xref>).</p><p>The pathological mechanism of HPV-induced PH involves a wide array of mechanisms and pathways. There is growing evidence that reactive oxygen species (ROS) increase as a result of hypoxia exposure and could play a key role in the pulmonary vasculature responses to hypoxia (<xref rid="B32" ref-type="bibr">Guzy and Schumacker, 2006</xref>). ROS can impair the activity of vasodilators or their production and can also elicit inflammatory processes leading to a local inflammatory environment in the pulmonary vasculature (<xref rid="B1" ref-type="bibr">Aggarwal et al., 2013</xref>; <xref rid="B100" ref-type="bibr">Wong et al., 2013</xref>). Moreover, the molecular mechanism in the pulmonary vasculature that is involved in the response to hypoxia depends on the time and type of exposure and on genetic and individual variabilities (<xref rid="B8" ref-type="bibr">Beall, 2006</xref>; <xref rid="B76" ref-type="bibr">Simonson et al., 2010</xref>; <xref rid="B68" ref-type="bibr">Scherrer et al., 2013</xref>).</p><p>For these reasons, this review attempts to provide comprehensive insight into the main factors, sources and mechanisms in the interactions between ROS and other cellular components in the development of vascular responses or diseases due to hypoxia and/or other similar stressors, with an emphasis on pulmonary vasculature under hypobaric hypoxic conditions.</p></sec><sec><title>Hypoxic Pulmonary Vasoconstriction, Remodeling, and ROS</title><p>As mentioned above, HPV is the main and unique response to hypoxia exposure, whose core mechanism resides in calcium flux. Interestingly, in turn, HPV is closely intertwined with ROS activity to elicit this critical response. Therefore, Ca<sup>2+</sup> plays a fundamental role in PA vasoconstriction (<xref rid="B22" ref-type="bibr">Dunham-Snary et al., 2017</xref>). However, whether the internal release of calcium (<xref rid="B29" ref-type="bibr">Gelband and Gelband, 1997</xref>) or the influx of extracellular calcium (<xref rid="B93" ref-type="bibr">Weissmann et al., 2006</xref>) triggers SMCs contraction is currently debated in the literature.</p><p>Thus, it is important to elucidate the role of ROS in the molecular mechanism underlying the increase in the intracellular calcium concentration ([Ca<sup>2+</sup>]<sub>i</sub>). Studies have shown that hypoxia-induced increases in [Ca<sup>2+</sup>]<sub>i</sub> in pulmonary artery SMCs (PASMCs) require an increase in ROS signaling, specifically those involving super oxide anion (O<sub>2</sub><sup>&#x02219;-</sup>) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) (<xref rid="B34" ref-type="bibr">Jefferson et al., 2004</xref>). Thus, oxidative signaling via ROS potentially triggers a Ca<sup>2+</sup> release from the sarcoplasmic reticulum (SR), allowing extracellular calcium to enter through voltage-dependent calcium channels (VDCCs) and allowing capacitive calcium entry through store-operated calcium channels, thereby resulting in contraction (<xref rid="B88" ref-type="bibr">Wang et al., 2004</xref>). Notwithstanding, the main source of calcium in this process remains unclear (<xref rid="B78" ref-type="bibr">Staiculescu et al., 2014</xref>). However, studies have shown that extracellular calcium influx caused possibly by hypoxia-induced ROS signaling is necessary to elicit the HPV response since removal of extracellular calcium ions abolishes the hypoxia-induced increase in [Ca<sup>2+</sup>]<sub>i</sub> in SMCs (<xref rid="B92" ref-type="bibr">Weir and Archer, 1995</xref>; <xref rid="B19" ref-type="bibr">Desireddi et al., 2010</xref>).</p><p>A sustained HPV could contribute to starting a vascular remodeling and the subsequent development of PH (<xref rid="B60" ref-type="bibr">Pe&#x000f1;aloza et al., 1971</xref>; <xref rid="B41" ref-type="bibr">Le&#x000f3;n-Velarde et al., 2010</xref>; <xref rid="B64" ref-type="bibr">Rimoldi et al., 2012</xref>). Under physiological conditions, the thickness of the vascular wall is maintained by a fine balance between cellular proliferation and apoptosis (<xref rid="B58" ref-type="bibr">Pak et al., 2007</xref>; <xref rid="B95" ref-type="bibr">Welsh and Peacock, 2013</xref>). If this balance is disrupted in favor of decreased apoptosis and increased proliferation, the vascular wall thickens and can eventually obstruct the vessel lumen. This structural process, which leads to augmented resistance, is known as vascular remodeling (<xref rid="B37" ref-type="bibr">Kato and Staub, 1966</xref>). This remodeling effect can be rapidly initiated (<xref rid="B35" ref-type="bibr">Jensen et al., 1992</xref>; <xref rid="B55" ref-type="bibr">Moudgil et al., 2005</xref>; <xref rid="B25" ref-type="bibr">Engelhardt et al., 2014</xref>). In addition, HPV has been documented in several animal models, including fetal lambs, newborn piglets, rats, and mice (<xref rid="B100" ref-type="bibr">Wong et al., 2013</xref>).</p><p>This imbalance, which might be triggered by oxidative stress in favor of proliferation, occurs in PAs via different processes: an inhibition of antimitogenic factors (e.g., NO and prostacyclin) and increased synthesis and release of different mitogenic stimuli [endothelin-1 (ET-1), 5-hydroxytryptamine platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF)]. There is also a third relevant mechanism: an increased production of extracellular matrix components (<xref rid="B80" ref-type="bibr">Stenmark and Mecham, 1997</xref>) through the release of inflammatory mediators [interleukin (IL)-6, IL-8, IL-22, signal transducer and activator of transcription 3 (STAT3), nuclear factor of activated T-cells, stromal cell-derived factor-1, monocyte chemoattractant factor-1 (<xref rid="B38" ref-type="bibr">Kishimoto et al., 2015</xref>) and inducible-nitric oxide synthase (iNOS) (<xref rid="B86" ref-type="bibr">Visser et al., 2010</xref>; <xref rid="B6" ref-type="bibr">Bansal et al., 2013</xref>), among others]. It is noteworthy that not all inflammatory mediators participate in remodeling or PH such as IL-4/IL-13, STAT6, and TLR-MyD88 (<xref rid="B24" ref-type="bibr">El Kasmi et al., 2014</xref>).</p><sec><title>Controversial Effects of HPV and ROS on Potassium Channels (K<sup>+</sup> Channels)</title><p>Although redox signaling has been suggested to be a crucial event in HPV and remodeling, whether an increase or decrease in ROS triggers these processes has been debated (<xref rid="B90" ref-type="bibr">Waypa et al., 2002</xref>). First, studies have noted that hypoxia decreases the generation of ROS in PASMCs and shifts the cytosol into a more reduced state, which alters the redox-sensitive thiol groups in the regulatory subunits of Kv channels (Kv2.1), causing the channels to close and altering the resting membrane potential (E<sub>m</sub>) in PASMCs. Membrane depolarization then leads to voltage-gated (L-type) calcium channel opening followed by an influx of extracellular calcium into the cytoplasm, resulting in vasoconstriction (<xref rid="B92" ref-type="bibr">Weir and Archer, 1995</xref>; <xref rid="B4" ref-type="bibr">Archer et al., 1998</xref>). These results are derived from studies on isolated PASMCs, thus simulating a hypoxic environment with powerful reducing agents, such as sodium dithionite, and the subsequent response in potassium currents (hypoxic inhibition of potassium current) may be specific for PASMCs rather than systemic artery SMCs. However, the same studies have shown that the use of sodium dithionite (an oxygen tension-reducing agent) increases the production of superoxide anions and hydrogen peroxide as much as it reduces oxygen tension (<xref rid="B22" ref-type="bibr">Dunham-Snary et al., 2017</xref>). Although HPV is an intrinsic response of pulmonary vasculature when there is a K<sup>+</sup> channel blockage, both vasculatures respond with a vasoconstriction (<xref rid="B61" ref-type="bibr">Post et al., 1992</xref>). Thus, the most likely explanation of the heterogenic response in systemic and pulmonary vasculature, under hypoxia, would lie in the different cellular mechanisms induced by hypoxia itself (<xref rid="B22" ref-type="bibr">Dunham-Snary et al., 2017</xref>). The mentioned discrepancies regarding whether hypoxia leads to an oxidized state with high ROS levels or a reduced state with low ROS levels may be explained by the diversity of methodology or models, including type of artery, severity and type of hypoxia, time of exposure, pH and PCO<sub>2</sub> disturbances, and type of cellular layer.</p></sec></sec><sec><title>Oxidative Stress, ROS, and Hypoxia</title><p>Oxidative stress is a condition that occurs when there is an increase in ROS at the cellular level. ROS represent a set of reactive species that are derived from oxygen that have one or more unpaired electrons in their outer orbital layer, which make them very unstable and highly reactive. For these reasons, ROS can bind to and oxidize different cellular compounds (lipid, DNA, protein, and cellular membrane, among others), thereby modifying their structure and function and activating cellular signaling (<xref rid="B34" ref-type="bibr">Jefferson et al., 2004</xref>; <xref rid="B53" ref-type="bibr">Montezano and Touyz, 2012</xref>). Known free radicals include superoxide anion (O<sub>2</sub><sup>&#x02219;-</sup>), hydroxyl ion (OH), peroxyl (RO<sub>2</sub>), and alkoxy agents (RO<sup>.</sup>). Certain non-radicals that are either oxidizing or easily converted into oxidative elements include hypochlorous acid (HOCl), ozone (O<sub>3</sub>), singlet oxygen (<sup>1</sup>O<sub>2</sub>), and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Notably, there are other oxidative ions that contain nitrogen and can contribute with a nitrosative stress under the name of reactive nitrogen species. The most representative species is peroxynitrite ion (ONOO<sup>-</sup>), which is derived from NO and O<sub>2</sub><sup>&#x02219;-</sup> binding (<xref rid="B62" ref-type="bibr">Radi et al., 1991</xref>; <xref rid="B9" ref-type="bibr">Beckman and Koppenol, 1996</xref>).</p><p>Despite the apparent paradox whereby, in a hypoxic environment, there is more oxidative stress, which has generated a long debate, it is currently agreed that hypoxia and consequently PH are associated with a high level of oxidative stress (<xref rid="B12" ref-type="bibr">Bowers et al., 2004</xref>; <xref rid="B32" ref-type="bibr">Guzy and Schumacker, 2006</xref>). Several studies have provided evidence of this phenomenon. Using F<sub>2</sub>-isoprostane levels in urine as a sensitive biomarker of oxidative stress (<xref rid="B20" ref-type="bibr">Dorjgochoo et al., 2012</xref>), ROS levels were observed to be two- to threefold higher in PH patients than in control subjects (<xref rid="B100" ref-type="bibr">Wong et al., 2013</xref>). Likewise, higher plasma concentrations of malondialdehyde (MDA), a compound derived from oxidative stress-induced lipid oxidation, have been reported in patients with idiopathic pulmonary arterial hypertension (<xref rid="B33" ref-type="bibr">Irodova et al., 2002</xref>) and in rats under hypobaric hypoxia (<xref rid="B45" ref-type="bibr">L&#x000fc;neburg et al., 2016</xref>). Similarly, in endothelial cells, increased levels of 8-hydroxy-deoxyguanosine (8-OHdG), a marker of deoxyribonucleic acid oxidation, have also been found (<xref rid="B12" ref-type="bibr">Bowers et al., 2004</xref>; <xref rid="B38" ref-type="bibr">Kishimoto et al., 2015</xref>). Thus, an increase in ROS might lead to inflammation, hypertrophy, cellular proliferation, apoptosis, migration, and fibrosis (<xref rid="B99" ref-type="bibr">Wong et al., 2017</xref>) while also generating an endothelial dysfunction (<xref rid="B53" ref-type="bibr">Montezano and Touyz, 2012</xref>), all of which are components of the remodeling process, which will ultimately manifest in a PH. Therefore, ROS imbalance as a result of hypoxia may be strongly involved in the hypoxic response of pulmonary vasculature at any hypoxic condition, and restoring this balance has prompted several studies.</p><sec><title>Main Sources of ROS in the Vascular System Under Hypoxic Conditions</title><p>Reactive oxygen species can be produced as a sub-product of the electron transporter chain (ETC) in the mitochondria. The ETC is composed of four mega-complexes that mediate the transfer of electrons down a redox potential gradient through a series of carriers, resulting in the acceptance of an electron by O<sub>2</sub> and producing ATP and water (<xref rid="B55" ref-type="bibr">Moudgil et al., 2005</xref>). A small percentage of total electron flux involves unpaired electrons, resulting in the generation of ROS, notably superoxide radicals, within the mitochondrion. To remove this latter ROS, mitochondria express a unique, inducible isoform of superoxide dismutase (SOD2, manganese SOD or MnSOD). MnSOD transforms toxic superoxide radicals into H<sub>2</sub>O<sub>2</sub>, which can in turn serve as a diffusible redox mediator in HPV (<xref rid="B3" ref-type="bibr">Archer et al., 1993</xref>). Interestingly, the release of superoxides through enzymes and anion channels within the mitochondria of PASMCs can be modulated by diffusible H<sub>2</sub>O<sub>2</sub> (<xref rid="B55" ref-type="bibr">Moudgil et al., 2005</xref>). Additionally, the relationship between mitochondrial ROS and PA remodeling in response to CH is supported by the observation that depletion of Rieske iron-sulfur protein (RISP), a mitochondrial complex III protein that is required for ROS generation, in mouse ECs and SMCs prevents CH-induced PH (<xref rid="B32" ref-type="bibr">Guzy and Schumacker, 2006</xref>; <xref rid="B89" ref-type="bibr">Waypa et al., 2016</xref>).</p><p>Increasing evidence suggests that the principal source of ROS in the cardiovascular system is the enzymatic complex nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) (<xref rid="B55" ref-type="bibr">Moudgil et al., 2005</xref>). The NADPH oxidase complex is structurally composed of transmembrane and cytosolic proteins that use NADPH as the electron donor to reduce molecular oxygen to O<sub>2</sub><sup>&#x02219;-</sup> and H<sub>2</sub>O<sub>2</sub>. Studies have characterized seven members of the NOX family of NADPH oxidases (NOX1&#x02013;5 and dual oxidase 1 and 2), which are expressed within specific tissues and organs (<xref rid="B5" ref-type="bibr">Bache and Chen, 2014</xref>), including neurons, skeletal muscle, myocytes, hepatocytes, ECs, hematopoietic cells, stem cells, and cardiomyocytes (<xref rid="B105" ref-type="bibr">Yu et al., 2016</xref>). However, NOX4 has been reported as the most prevalent subunit in the cardiovascular system (<xref rid="B16" ref-type="bibr">Chen et al., 2012</xref>).</p><p>The oxidase role of NADPH has been further supported using animal models with antioxidant overexpression such as catalase or glutathione peroxidase-1 (GP<sub>x1</sub>). Further, experimental pharmacologic intervention with antioxidants and anti-inflammatory products (probucol, <italic>N</italic>-acetylcysteine, tempol, erdosteine, allicin, pyrrolidine dithiocarbamate, superoxide dismutase, allopurinol, sulfur dioxide, resveratrol, hydrogen water, and EUK-134) have been demonstrated to ameliorate or inhibit PH and right ventricular dysfunction (<xref rid="B90" ref-type="bibr">Waypa et al., 2002</xref>; <xref rid="B100" ref-type="bibr">Wong et al., 2013</xref>; <xref rid="B38" ref-type="bibr">Kishimoto et al., 2015</xref>). However, it is important to highlight that clinical studies have shown inconclusive results using pharmacological or dietary antioxidant treatments, despite the ample evidence on the importance of ROS in experimental models. It is likely that the precise mechanism of ROS and the pharmacokinetics of antioxidants in humans are still not well understood in hypoxic diseases (<xref rid="B100" ref-type="bibr">Wong et al., 2013</xref>).</p></sec><sec><title>The Oxidase Role of NADPH</title><p>There is evidence of increased mRNA and protein expression of a specific NADPH isoform, NOX4, in the lungs of rats exposed to chronic hypobaric hypoxia, presenting PH, in which the concentration of MDA is increased by up to twofold after CIH or CH exposure (<xref rid="B45" ref-type="bibr">L&#x000fc;neburg et al., 2016</xref>). In agreement with this evidence, silencing of NOX4 and p47phox (another subunit of NADPH oxidase) has been shown to attenuate oxidative stress and human and rat PASMC proliferation (<xref rid="B51" ref-type="bibr">Mittal et al., 2012</xref>). In addition, both chronic and intermittent hypoxia leads to a notable increase in superoxide radicals, which can impair and decrease NO bioavailability (<xref rid="B7" ref-type="bibr">Barman et al., 2014</xref>; <xref rid="B77" ref-type="bibr">Siques et al., 2014</xref>).</p><p>In contrast, recent studies have shown that NOX4 does not influence the development of hypoxia-induced pathologies in the lung such as HPV or PH (<xref rid="B85" ref-type="bibr">Veith et al., 2016</xref>). Supporting the above findings, augmented superoxide anion (O<sub>2</sub><sup>&#x02219;-</sup>) production has been detected in mice with NOX2- and NOX1-overexpressing SMCs. NOX1- and NOX2-derived O<sub>2</sub><sup>&#x02219;-</sup> may contribute to the formation of ONOO<sup>-</sup> and subsequently to vascular dysfunction, while NOX4 overexpression increases H<sub>2</sub>O<sub>2</sub> formation (<xref rid="B48" ref-type="bibr">Martyn et al., 2006</xref>; <xref rid="B73" ref-type="bibr">Serrander et al., 2007</xref>; <xref rid="B85" ref-type="bibr">Veith et al., 2016</xref>). The reason for the latter resides in the fact that NOX4 may be incapable of scavenging NO in the PA due to a rapid dismutation of O<sub>2</sub><sup>&#x02219;-</sup> to H<sub>2</sub>O<sub>2</sub> before its release from the enzyme (<xref rid="B84" ref-type="bibr">Takac et al., 2011</xref>). Nevertheless, NOX4-produced H<sub>2</sub>O<sub>2</sub> can also elicit different effects depending on its concentration, ranging from a beneficial effect on endothelial cell activity in PAs at low H<sub>2</sub>O<sub>2</sub> concentrations to the development of SMC hypertrophy at high H<sub>2</sub>O<sub>2</sub> concentrations (<xref rid="B70" ref-type="bibr">Schr&#x000f6;der et al., 2012</xref>; <xref rid="B85" ref-type="bibr">Veith et al., 2016</xref>). Therefore, the precise role of each of the NADPH subunits in hypoxia appears to be controversial. However, until recently, NOX4 was considered to be the most relevant according to several authors (<xref rid="B81" ref-type="bibr">Sturrock et al., 2006</xref>; <xref rid="B52" ref-type="bibr">Mittal et al., 2007</xref>; <xref rid="B57" ref-type="bibr">Nisbet et al., 2009</xref>). Drawing a definite conclusion will require further research.</p></sec></sec><sec><title>Pulmonary Arterial Layers, Fibroblasts, and ROS in Hypoxia</title><sec><title>Adventitial Cells</title><p>Hypoxia induces a more than twofold increase in adventitial thickness in PAs via both fibroblast hypertrophy and hyperplasia and an increase in the surrounding collagen matrix (<xref rid="B49" ref-type="bibr">Meyrick and Reid, 1979</xref>). A recent study in rats under CIH showed increased the cellularity of inflammatory cells without changes in lumen size as distinctive features of this condition (<xref rid="B13" ref-type="bibr">Brito et al., 2015</xref>). The main trigger or regulator of these processes would be ROS (<xref rid="B96" ref-type="bibr">Welsh et al., 2001</xref>). Under hypoxic conditions, fibroblasts appear as key cells as a result of their capacity to migrate into the medial layer and transform into SMCs (<xref rid="B79" ref-type="bibr">Stenmark et al., 2002</xref>), thus contributing to vascular remodeling. Moreover, resident adventitial cells could also be activated and reprogrammed for several different behaviors, participating in remodeling and SMC tone (<xref rid="B95" ref-type="bibr">Welsh and Peacock, 2013</xref>).</p><p>Thus, under hypoxic conditions, adventitial fibroblasts would also act via the generation of matrix proteins (<xref rid="B66" ref-type="bibr">Sartore et al., 2001</xref>), which contribute to the narrowing of the vascular lumen, via cytokines, growth factors, and inflammatory mediators [IL-6, STAT3, hypoxia-inducible factor-1 (HIF-1), and C/EBP&#x003b2;]. The last one has been shown to be paracrine regulators of vascular macrophages for chronic inflammation, remodeling, and PH (<xref rid="B24" ref-type="bibr">El Kasmi et al., 2014</xref>).</p><p>The molecular mechanism by which hypoxia stimulates proliferation in PA fibroblasts is under study. Nevertheless, there is evidence that mitogen-activated protein (MAP) kinase, Erk1/2 and related stress-activated kinases, such as Jnk and p38 MAP kinase, are key regulators of cell proliferation and can be activated in response to hypoxic stress (<xref rid="B72" ref-type="bibr">Seko et al., 1996</xref>; <xref rid="B65" ref-type="bibr">Robinson and Cobb, 1997</xref>; <xref rid="B17" ref-type="bibr">Das et al., 2001</xref>). Further support for the role of hypoxia-induced oxidative stress in the activation of these protein kinases has been described (<xref rid="B23" ref-type="bibr">Dworakowski et al., 2006</xref>; <xref rid="B69" ref-type="bibr">Schr&#x000f6;der et al., 2009</xref>; <xref rid="B53" ref-type="bibr">Montezano and Touyz, 2012</xref>; <xref rid="B104" ref-type="bibr">Yamada et al., 2012</xref>). In addition, recent studies show that HIF-1&#x003b1; stabilization in all PA cells elicits the production of ROS via p22phox-containing NADPH oxidase. Therefore, HIF-1&#x003b1;-induced ROS production might contribute to the activation of PA fibroblasts and could be another mechanism by which hypoxia induces PA fibroblast proliferation (<xref rid="B96" ref-type="bibr">Welsh et al., 2001</xref>). Controversially, a recent cell culture study reported that ROS levels in human fibroblasts decrease under hypoxic conditions (<xref rid="B74" ref-type="bibr">Sgarbi et al., 2017</xref>); however, this finding requires further verification.</p><p>Another mechanism for fibroblast proliferation under hypoxia would involve their capacity to transdifferentiate into other cell types such as myofibroblasts through a complex network of microenvironmental factors and extracellular matrix components (<xref rid="B79" ref-type="bibr">Stenmark et al., 2002</xref>).</p></sec><sec><title>Smooth Muscle Cells</title><p>It is well known that medial thickness greatly determines pulmonary vascular resistance. The pre-capillary segment of the pulmonary vascular bed contributes to pulmonary vascular resistance and determines PA pressure. Under hypoxic conditions, these vessels enhance their muscularization (<xref rid="B49" ref-type="bibr">Meyrick and Reid, 1979</xref>), representing a key feature of hypoxic pulmonary vascular remodeling (<xref rid="B58" ref-type="bibr">Pak et al., 2007</xref>). This effect has been observed in CH (<xref rid="B59" ref-type="bibr">Penaloza and Arias-Stella, 2007</xref>) and CIH, but to a lesser extent (<xref rid="B13" ref-type="bibr">Brito et al., 2015</xref>). Whether acute hypoxia has proliferative effects on PASMCs is controversial, though several studies have demonstrated either increased ROS levels or cellular proliferation in acute hypoxia (<xref rid="B91" ref-type="bibr">Wedgwood et al., 2001</xref>).</p><p>Vascular SMCs play important roles in the physiological regulation of vascular tone and vascular remodeling. The mechanisms by which hypoxia lead pulmonary vessels to constrict and coronary vessels to relax are subject to ongoing research. Hypoxia-induced closure of Kv channels could be the result of a change in cytoplasmic ROS or redox status in PASMCs. Moreover, NADPH oxidase has been shown to bind the &#x003b2;-subunit of Kv channels, thus supporting a link between ROS and K<sup>+</sup> channels and cellular excitability (<xref rid="B102" ref-type="bibr">Wu et al., 2007</xref>).</p><p>Notably, ET-1 is upregulated during hypoxia and has been demonstrated to influence SMC proliferation via NADPH oxidase-derived superoxides and to contribute to the pathogenesis of hypoxic-induced PH (<xref rid="B47" ref-type="bibr">Madden et al., 1992</xref>; <xref rid="B42" ref-type="bibr">Li et al., 1994</xref>; <xref rid="B43" ref-type="bibr">Liu et al., 2007</xref>). Moreover, administration of ET-1 significantly increases ROS production in both PASMCs and coronary artery SMCs (<xref rid="B102" ref-type="bibr">Wu et al., 2007</xref>), whereas inhibition of NADPH oxidase in bovine fetal PASMCs activates the apoptosis process and avoids ET-1-mediated SMC proliferation (<xref rid="B102" ref-type="bibr">Wu et al., 2007</xref>).</p><p>The role of ROS SMC proliferation is also a controversial issue. While one study has shown that acute hypoxia significantly reduces superoxide production in both human PASMCs and coronary arterial SMCs (<xref rid="B31" ref-type="bibr">Gupte and Wolin, 2006</xref>), others have demonstrated increased ROS production in pulmonary arteries due to acute hypoxia and CIH (<xref rid="B91" ref-type="bibr">Wedgwood et al., 2001</xref>; <xref rid="B71" ref-type="bibr">Schumacker, 2011</xref>; <xref rid="B77" ref-type="bibr">Siques et al., 2014</xref>). There are several explanations for the lack of superoxide: a differential regulation of NADPH oxidases due to higher basal cytosolic NADPH oxidase levels in PAs (<xref rid="B31" ref-type="bibr">Gupte and Wolin, 2006</xref>), a subcellular localization of NOX, which may be critical for the activation of downstream signaling, and differences in SOD activity between PASMC and coronary artery SMCs. Regrettably, the available literature does not allow a definitive explanation.</p><p>Another possible pathway involved in SMC proliferation could be explained by ROS-activated p38MAPK, as demonstrated in hypoxia-induced proliferation and contraction in rat PAs (<xref rid="B36" ref-type="bibr">Karamsetty et al., 2002</xref>). Remarkably, this latter effect has not been observed in systemic vasculature (<xref rid="B75" ref-type="bibr">Sigaud et al., 2005</xref>). In addition, carbonylation of annexin A1 may contribute to the development of vascular remodeling and PH since ET-1 and serotonin (5-HT) in PASMCs could promote the carbonylation of annexin A1 protein (<xref rid="B101" ref-type="bibr">Wong et al., 2008</xref>). Annexin A1 exerts anti-inflammatory, antiproliferative, and proapoptotic effects. Consequently, inhibition of protein carbonylation may be a novel therapeutic target for hypobaric hypoxia PH (<xref rid="B100" ref-type="bibr">Wong et al., 2013</xref>).</p></sec><sec><title>Endothelial Cells</title><p>The EC layer is in a unique position that allows it to respond to circulatory and blood factors, acting as a vasculature integrator, modulator, and signal transducer via paracrine signaling (<xref rid="B28" ref-type="bibr">Furchgott and Zawadzki, 1980</xref>).</p><p>Under hypoxic conditions, an endothelial dysfunction occurs that not only alters the vascular tone but also contributes with inflammatory and proliferative mediators, ultimately leading to vascular remodeling (<xref rid="B30" ref-type="bibr">Griendling and Ushio-Fukai, 2000</xref>). Thus, ECs regulate the vascular tone and pulmonary remodeling by producing vasodilator and antiproliferative NO or vasoconstrictive pro-proliferative factors (ET-1, angiotensin II, thromboxane A<sub>2</sub> and PDGF-B; <xref rid="B58" ref-type="bibr">Pak et al., 2007</xref>) that are exclusive to ECs but not to SMCs (<xref rid="B2" ref-type="bibr">Ambalavanan et al., 1999</xref>).</p><p>A main endogenous vasodilator and antiproliferative is NO, which is synthetized in ECs by endothelial nitric oxide synthase (eNOS), through stimulation of soluble guanylyl cyclase (sGC) to increase the level of cyclic GMP in SMCs (<xref rid="B26" ref-type="bibr">F&#x000f6;rstermann et al., 1986</xref>). Therefore, lesser NO availability would lead to endothelial dysfunction (<xref rid="B15" ref-type="bibr">Cai and Harrison, 2000</xref>; <xref rid="B98" ref-type="bibr">Wolin et al., 2010</xref>; <xref rid="B27" ref-type="bibr">Frazziano et al., 2012</xref>). Increased ROS levels under hypoxia have been widely demonstrated during this review and would play a key role in impairing NO production and bioavailability (<xref rid="B15" ref-type="bibr">Cai and Harrison, 2000</xref>; <xref rid="B77" ref-type="bibr">Siques et al., 2014</xref>). The described mechanisms through which ROS would alter NO levels in ECs include NO degradation, ONOO<sup>-</sup> production, and increasing oxidative stress (<xref rid="B62" ref-type="bibr">Radi et al., 1991</xref>; <xref rid="B50" ref-type="bibr">Millatt et al., 2003</xref>; <xref rid="B82" ref-type="bibr">Sun et al., 2010</xref>; <xref rid="B21" ref-type="bibr">Dumitrascu et al., 2013</xref>), stimulation of uncoupled eNOS formation (BH4 decreased) (<xref rid="B82" ref-type="bibr">Sun et al., 2010</xref>), stimulation of iNOS activity and enhancement of O<sub>2</sub>-production (<xref rid="B44" ref-type="bibr">Loscalzo, 2001</xref>).</p><p>Interestingly, enhanced associations between iNOS and asymmetric dimethylarginine (ADMA) level leading to airway inflammation and also in the vasculature have been described (<xref rid="B94" ref-type="bibr">Wells and Holian, 2007</xref>; <xref rid="B86" ref-type="bibr">Visser et al., 2010</xref>). ADMA induces a decrease in endothelium-dependent vasodilation through the inhibition of eNOS (<xref rid="B10" ref-type="bibr">B&#x000f6;ger, 2006</xref>; <xref rid="B97" ref-type="bibr">Wilcken et al., 2007</xref>). ADMA also interacts with ROS in the vasculature by disturbing the usual flow of electrons between the two domains of eNOS, becoming a generator of superoxide radicals instead of NO (<xref rid="B83" ref-type="bibr">Sydow and M&#x000fc;nzel, 2003</xref>). Recently, it has been demonstrated that exposure to CIH and CH induces a steady increase of ADMA in human (<xref rid="B46" ref-type="bibr">L&#x000fc;neburg et al., 2017</xref>) and rat models (<xref rid="B45" ref-type="bibr">L&#x000fc;neburg et al., 2016</xref>). Therefore, this mechanism could also contribute to the hypoxic inflammatory status, hypoxic endothelial dysfunction, and subsequent vascular remodeling.</p><p>A limitation of this review is that it focuses mainly on hypobaric hypoxia, which is the hypoxia experienced at high altitude, but it was also necessary to include studies conducted in either simulated hypobaric or normobaric hypoxia. This could introduce some bias because it has been well determined that different responses can occur according to the source of the hypoxia (<xref rid="B67" ref-type="bibr">Savourey et al., 2003</xref>; <xref rid="B11" ref-type="bibr">Bonetti et al., 2009</xref>; <xref rid="B18" ref-type="bibr">Debevec and Millet, 2014</xref>).</p></sec></sec><sec><title>Conclusion</title><p>This review provides information supporting the role of oxidative stress (mainly ROS) in the pulmonary vasculature&#x02019;s responses under hypobaric hypoxia and depicting possible future therapeutic and research targets. NADPH oxidase-produced oxidative stress is highlighted as a major source of ROS. Moreover, new molecules, such as ADMA, and critical inflammatory cells as fibroblasts, could be also involved. Several controversies still remain regarding the roles of ROS and the mechanisms involved in hypoxic responses. Despite the latter, these mechanisms, independently or cooperatively, could contribute to the responses of the pulmonary vasculature to hypoxia, ultimately resulting in PH.</p><p>Finally, a schematic summarizing the most feasible and hypothetic mechanisms involved in the relationship between ROS and pulmonary vascular cells under hypobaric hypoxic conditions, as a result of this review, is provided in <bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Proposed scheme: the most feasible and hypothetic mechanisms involved in the relationship between ROS and pulmonary vascular cells under hypobaric hypoxic conditions are summarized. Ca<sup>2+</sup>, calcium; ROS, reactive oxygen species; SR, sarcoplasmic reticulum; 5-HT, serotonin; ET-1, endothelin-1; IL-6, interleukin 6; IL-1, interleukin 1; STAT3, signal transducer and activator of transcription 3; HIF-1, hypoxia-inducible factor 1; C/EBP&#x003b2;, CCAAT/enhancer-binding protein beta; PDGF-B, platelet-derived growth factor subunit B; VEGF, vascular endothelial growth factor; IGF-1, insulin-like growth factor; ONOO<sup>-</sup>, peroxynitrite; ADMA, asymmetric dimethylarginine; eNOS, endothelial nitric oxide synthase; iNOS, inducible nitric oxide synthase; BH4, tetrahydrobiopterin; VDCCs, voltage-dependent calcium channels; O<sub>2</sub><sup>&#x02219;-</sup>, superoxide anion; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; CaMK, Ca<sup>2+</sup>/calmodulin-dependent protein kinase.</p></caption><graphic xlink:href="fphys-09-00865-g001"/></fig></sec><sec><title>Author Contributions</title><p>PS, JB, and EP equally contributed to the design of the review, gathering of information, analysis of literature, and drafting of the manuscript. All of the authors approved the final manuscript and agreed to be accountable for all aspects of the work.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by grants from FIC-TARAPACA (BIP 30434827-0) and FIC-TARAPACA (BIP 30477541-0).</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>S.</given-names></name><name><surname>Gross</surname><given-names>C. M.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Fineman</surname><given-names>J. R.</given-names></name><name><surname>Black</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Reactive oxygen species in pulmonary vascular remodeling.</article-title>
<source><italic>Compr. Physiol.</italic></source>
<volume>3</volume>
<fpage>1011</fpage>&#x02013;<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1002/cphy.c120024</pub-id>
<?supplied-pmid 23897679?><pub-id pub-id-type="pmid">23897679</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambalavanan</surname><given-names>N.</given-names></name><name><surname>Mariani</surname><given-names>G.</given-names></name><name><surname>Bulger</surname><given-names>A.</given-names></name><name><surname>Philips</surname><given-names>J. B.</given-names><suffix>III.</suffix></name></person-group> (<year>1999</year>). <article-title>Role of nitric oxide in regulating neonatal porcine pulmonary artery smooth muscle cell proliferation.</article-title>
<source><italic>Biol. Neonate</italic></source>
<volume>76</volume>
<fpage>291</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1159/000014171</pub-id>
<?supplied-pmid 10516396?><pub-id pub-id-type="pmid">10516396</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Archer</surname><given-names>S. L.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Henry</surname><given-names>T.</given-names></name><name><surname>Peterson</surname><given-names>D.</given-names></name><name><surname>Weir</surname><given-names>E. K.</given-names></name></person-group> (<year>1993</year>). <article-title>A redox-based O2 sensor in rat pulmonary vasculature.</article-title>
<source><italic>Circ. Res.</italic></source>
<volume>73</volume>
<fpage>1100</fpage>&#x02013;<lpage>1112</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.73.6.1100</pub-id>
<?supplied-pmid 8222081?><pub-id pub-id-type="pmid">8222081</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Archer</surname><given-names>S. L.</given-names></name><name><surname>Souil</surname><given-names>E.</given-names></name><name><surname>Dinh-Xuan</surname><given-names>A. T.</given-names></name><name><surname>Schremmer</surname><given-names>B.</given-names></name><name><surname>Mercier</surname><given-names>J. C.</given-names></name><name><surname>El Yaagoubi</surname><given-names>A.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Molecular identification of the role of voltage-gated K + channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes.</article-title>
<source><italic>J. Clin. Invest.</italic></source>
<volume>101</volume>
<fpage>2319</fpage>&#x02013;<lpage>2330</lpage>. <pub-id pub-id-type="doi">10.1172/JCI333</pub-id>
<?supplied-pmid 9616203?><pub-id pub-id-type="pmid">9616203</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bache</surname><given-names>R. J.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>NOX2-induced myocardial fibrosis and diastolic dysfunction: role of the endothelium.</article-title>
<source><italic>J. Am. Coll. Cardiol.</italic></source>
<volume>63</volume>
<fpage>2742</fpage>&#x02013;<lpage>2744</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2014.01.070</pub-id>
<?supplied-pmid 24681139?><pub-id pub-id-type="pmid">24681139</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>G.</given-names></name><name><surname>Das</surname><given-names>D.</given-names></name><name><surname>Hsieh</surname><given-names>C. Y.</given-names></name><name><surname>Wang</surname><given-names>Y. H.</given-names></name><name><surname>Gilmore</surname><given-names>B. A.</given-names></name><name><surname>Wong</surname><given-names>C. M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>IL-22 activates oxidant signaling in pulmonary vascular smooth muscle cells.</article-title>
<source><italic>Cell. Signal.</italic></source>
<volume>25</volume>
<fpage>2727</fpage>&#x02013;<lpage>2733</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2013.09.001</pub-id>
<?supplied-pmid 24018041?><pub-id pub-id-type="pmid">24018041</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barman</surname><given-names>S. A.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Dimitropoulou</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Catravas</surname><given-names>J. D.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.</article-title>
<source><italic>Arterioscler. Thromb. Vasc. Biol.</italic></source>
<volume>34</volume>
<fpage>1704</fpage>&#x02013;<lpage>1715</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.114.303848</pub-id>
<?supplied-pmid 24947524?><pub-id pub-id-type="pmid">24947524</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beall</surname><given-names>C. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Andean, tibetan, and ethiopian patterns of adaptation to high-altitude hypoxia.</article-title>
<source><italic>Integr. Comp. Biol.</italic></source>
<volume>46</volume>
<fpage>18</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1093/icb/icj004</pub-id>
<?supplied-pmid 21672719?><pub-id pub-id-type="pmid">21672719</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckman</surname><given-names>J. S.</given-names></name><name><surname>Koppenol</surname><given-names>W. H.</given-names></name></person-group> (<year>1996</year>). <article-title>Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.</article-title>
<source><italic>Am. J. Physiol.</italic></source>
<volume>271</volume>
<fpage>C1424</fpage>&#x02013;<lpage>C1437</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.1996.271.5.C1424</pub-id>
<?supplied-pmid 8944624?><pub-id pub-id-type="pmid">8944624</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f6;ger</surname><given-names>R. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond.</article-title>
<source><italic>Ann. Med.</italic></source>
<volume>38</volume>
<fpage>126</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1080/07853890500472151</pub-id>
<?supplied-pmid 16581698?><pub-id pub-id-type="pmid">16581698</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonetti</surname><given-names>D. L.</given-names></name><name><surname>Hopkins</surname><given-names>W. G.</given-names></name><name><surname>Lowe</surname><given-names>T. E.</given-names></name><name><surname>Boussana</surname><given-names>A.</given-names></name><name><surname>Kilding</surname><given-names>A. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Cycling performance following adaptation to two protocols of acutely intermittent hypoxia.</article-title>
<source><italic>Int. J. Sports Physiol. Perform.</italic></source>
<volume>4</volume>
<fpage>68</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1123/ijspp.4.1.68</pub-id>
<?supplied-pmid 19417229?><pub-id pub-id-type="pmid">19417229</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowers</surname><given-names>R.</given-names></name><name><surname>Cool</surname><given-names>C.</given-names></name><name><surname>Murphy</surname><given-names>R. C.</given-names></name><name><surname>Tuder</surname><given-names>R. M.</given-names></name><name><surname>Hopken</surname><given-names>M. W.</given-names></name><name><surname>Flores</surname><given-names>S. C.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Oxidative stress in severe pulmonary hypertension.</article-title>
<source><italic>Am. J. Respir. Crit. Care Med.</italic></source>
<volume>169</volume>
<fpage>764</fpage>&#x02013;<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200301-147OC</pub-id>
<?supplied-pmid 14701708?><pub-id pub-id-type="pmid">14701708</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>J.</given-names></name><name><surname>Siques</surname><given-names>P.</given-names></name><name><surname>Arribas</surname><given-names>S. M.</given-names></name><name><surname>L&#x000f3;pez de Pablo</surname><given-names>A. L.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>M. C.</given-names></name><name><surname>Naveas</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Adventitial alterations are the main features in pulmonary artery remodeling due to long-term chronic intermittent hypobaric hypoxia in rats.</article-title>
<source><italic>Biomed. Res. Int.</italic></source>
<volume>2015</volume>:<issue>169841</issue>. <pub-id pub-id-type="doi">10.1155/2015/169841</pub-id>
<?supplied-pmid 25738150?><pub-id pub-id-type="pmid">25738150</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>J.</given-names></name><name><surname>Siqu&#x000e9;s</surname><given-names>P.</given-names></name><name><surname>Le&#x000f3;n-Velarde</surname><given-names>F.</given-names></name><name><surname>De La Cruz</surname><given-names>J. J.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>V.</given-names></name><name><surname>Herruzo</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Chronic intermittent hypoxia at high altitude exposure for over 12 years: assessment of hematological, cardiovascular, and renal effects.</article-title>
<source><italic>High Alt. Med. Biol.</italic></source>
<volume>8</volume>
<fpage>236</fpage>&#x02013;<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2007.8310</pub-id>
<?supplied-pmid 17824824?><pub-id pub-id-type="pmid">17824824</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H.</given-names></name><name><surname>Harrison</surname><given-names>D. G.</given-names></name></person-group> (<year>2000</year>). <article-title>Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.</article-title>
<source><italic>Circ. Res.</italic></source>
<volume>87</volume>
<fpage>840</fpage>&#x02013;<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.87.10.840</pub-id><pub-id pub-id-type="pmid">11073878</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Haigh</surname><given-names>S.</given-names></name><name><surname>Barman</surname><given-names>S.</given-names></name><name><surname>Fulton</surname><given-names>D. J.</given-names></name></person-group> (<year>2012</year>). <article-title>From form to function: the role of Nox4 in the cardiovascular system.</article-title>
<source><italic>Front. Physiol.</italic></source>
<volume>3</volume>:<issue>412</issue>
<pub-id pub-id-type="doi">10.3389/fphys.2012.00412</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>M.</given-names></name><name><surname>Bouchey</surname><given-names>D. M.</given-names></name><name><surname>Moore</surname><given-names>M. J.</given-names></name><name><surname>Hopkins</surname><given-names>D. C.</given-names></name><name><surname>Nemenoff</surname><given-names>R. A.</given-names></name><name><surname>Stenmark</surname><given-names>K. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on G protein-mediated activation of mitogen-activated protein kinases.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>276</volume>
<fpage>15631</fpage>&#x02013;<lpage>15640</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M010690200</pub-id>
<?supplied-pmid 11278727?><pub-id pub-id-type="pmid">11278727</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debevec</surname><given-names>T.</given-names></name><name><surname>Millet</surname><given-names>G. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Discerning normobaric and hypobaric hypoxia: significance of exposure duration.</article-title>
<source><italic>J. Appl. Physiol.</italic></source>
<volume>116</volume>:<issue>1255</issue>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00873.2013</pub-id>
<?supplied-pmid 24789886?><pub-id pub-id-type="pmid">24789886</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desireddi</surname><given-names>J. R.</given-names></name><name><surname>Farrow</surname><given-names>K. N.</given-names></name><name><surname>Marks</surname><given-names>J. D.</given-names></name><name><surname>Waypa</surname><given-names>G. B.</given-names></name><name><surname>Schumacker</surname><given-names>P. T.</given-names></name></person-group> (<year>2010</year>). <article-title>Hypoxia increases ROS signaling and cytosolic Ca2 + in pulmonary artery smooth muscle cells of mouse lungs slices.</article-title>
<source><italic>Antioxid. Redox Signal.</italic></source>
<volume>12</volume>
<fpage>595</fpage>&#x02013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2009.2862</pub-id>
<?supplied-pmid 19747064?><pub-id pub-id-type="pmid">19747064</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorjgochoo</surname><given-names>T.</given-names></name><name><surname>Gao</surname><given-names>Y. T.</given-names></name><name><surname>Chow</surname><given-names>W. H.</given-names></name><name><surname>Shu</surname><given-names>X. O.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Cai</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.</article-title>
<source><italic>Am. J. Clin. Nutr.</italic></source>
<volume>96</volume>
<fpage>405</fpage>&#x02013;<lpage>414</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.112.034918</pub-id>
<?supplied-pmid 22760572?><pub-id pub-id-type="pmid">22760572</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumitrascu</surname><given-names>R.</given-names></name><name><surname>Heitmann</surname><given-names>J.</given-names></name><name><surname>Seeger</surname><given-names>W.</given-names></name><name><surname>Weissmann</surname><given-names>N.</given-names></name><name><surname>Schulz</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Obstructive sleep apnea, oxidative stress and cardiovascular disease: lessons from animal studies.</article-title>
<source><italic>Oxid. Med. Cell Longev.</italic></source>
<volume>2013</volume>:<issue>234631</issue>. <pub-id pub-id-type="doi">10.1155/2013/234631</pub-id>
<?supplied-pmid 23533685?><pub-id pub-id-type="pmid">23533685</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunham-Snary</surname><given-names>K. J.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Sykes</surname><given-names>E. A.</given-names></name><name><surname>Thakrar</surname><given-names>A.</given-names></name><name><surname>Parlow</surname><given-names>L. R. G.</given-names></name><name><surname>Mewburn</surname><given-names>J. D.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine.</article-title>
<source><italic>Chest</italic></source>
<volume>151</volume>
<fpage>181</fpage>&#x02013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.chest.2016.09.001</pub-id>
<?supplied-pmid 27645688?><pub-id pub-id-type="pmid">27645688</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dworakowski</surname><given-names>R.</given-names></name><name><surname>Anilkumar</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Shah</surname><given-names>A. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Redox signalling involving NADPH oxidase-derived reactive oxygen species.</article-title>
<source><italic>Biochem. Soc. Trans.</italic></source>
<volume>34</volume>
<fpage>960</fpage>&#x02013;<lpage>964</lpage>. <pub-id pub-id-type="doi">10.1042/BST0340960</pub-id>
<?supplied-pmid 17052237?><pub-id pub-id-type="pmid">17052237</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Kasmi</surname><given-names>K. C.</given-names></name><name><surname>Pugliese</surname><given-names>S. C.</given-names></name><name><surname>Riddle</surname><given-names>S. R.</given-names></name><name><surname>Poth</surname><given-names>J. M.</given-names></name><name><surname>Anderson</surname><given-names>A. L.</given-names></name><name><surname>Frid</surname><given-names>M. G.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.</article-title>
<source><italic>J. Immunol.</italic></source>
<volume>193</volume>
<fpage>597</fpage>&#x02013;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1303048</pub-id>
<?supplied-pmid 24928992?><pub-id pub-id-type="pmid">24928992</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelhardt</surname><given-names>S.</given-names></name><name><surname>Al-Ahmad</surname><given-names>A. J.</given-names></name><name><surname>Gassmann</surname><given-names>M.</given-names></name><name><surname>Ogunshola</surname><given-names>O. O.</given-names></name></person-group> (<year>2014</year>). <article-title>Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism.</article-title>
<source><italic>J. Cell. Physiol.</italic></source>
<volume>229</volume>
<fpage>1096</fpage>&#x02013;<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.24544</pub-id>
<?supplied-pmid 24375098?><pub-id pub-id-type="pmid">24375098</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>F&#x000f6;rstermann</surname><given-names>U.</given-names></name><name><surname>M&#x000fc;lsch</surname><given-names>A.</given-names></name><name><surname>B&#x000f6;hme</surname><given-names>E.</given-names></name><name><surname>Busse</surname><given-names>R.</given-names></name></person-group> (<year>1986</year>). <article-title>Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries.</article-title>
<source><italic>Circ. Res.</italic></source>
<volume>58</volume>
<fpage>531</fpage>&#x02013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.58.4.531</pub-id>
<?supplied-pmid 2870826?><pub-id pub-id-type="pmid">2870826</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frazziano</surname><given-names>G.</given-names></name><name><surname>Champion</surname><given-names>H. C.</given-names></name><name><surname>Pagano</surname><given-names>P. J.</given-names></name></person-group> (<year>2012</year>). <article-title>NADPH oxidase-derived ROS and theregulation of pulmonary vessel tone.</article-title>
<source><italic>Am. J. Physiol. Heart Circ. Physiol.</italic></source>
<volume>302</volume>
<fpage>H2166</fpage>&#x02013;<lpage>H2177</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00780.2011</pub-id>
<?supplied-pmid 22427511?><pub-id pub-id-type="pmid">22427511</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furchgott</surname><given-names>R. F.</given-names></name><name><surname>Zawadzki</surname><given-names>J. V.</given-names></name></person-group> (<year>1980</year>). <article-title>The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.</article-title>
<source><italic>Nature</italic></source>
<volume>288</volume>
<fpage>373</fpage>&#x02013;<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1038/288373a0</pub-id><pub-id pub-id-type="pmid">6253831</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelband</surname><given-names>C. H.</given-names></name><name><surname>Gelband</surname><given-names>H.</given-names></name></person-group> (<year>1997</year>). <article-title>Ca2 + release from intracellular stores is an initial step in hypoxic pulmonary vasoconstriction of rat pulmonary artery resistance vessels.</article-title>
<source><italic>Circulation</italic></source>
<volume>96</volume>
<fpage>3647</fpage>&#x02013;<lpage>3654</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.96.10.3647</pub-id>
<?supplied-pmid 9396467?><pub-id pub-id-type="pmid">9396467</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griendling</surname><given-names>K. K.</given-names></name><name><surname>Ushio-Fukai</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Reactive oxygen species as mediators of angiotensin II signaling.</article-title>
<source><italic>Regul. Pept.</italic></source>
<volume>91</volume>
<fpage>21</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">10967199</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupte</surname><given-names>S. A.</given-names></name><name><surname>Wolin</surname><given-names>M. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species.</article-title>
<source><italic>J. Appl. Physiol.</italic></source>
<volume>101</volume>
<fpage>1000</fpage>&#x02013;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00680.2006</pub-id>
<?supplied-pmid 16902073?><pub-id pub-id-type="pmid">16902073</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzy</surname><given-names>R. D.</given-names></name><name><surname>Schumacker</surname><given-names>P. T.</given-names></name></person-group> (<year>2006</year>). <article-title>Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia.</article-title>
<source><italic>Exp. Physiol.</italic></source>
<volume>91</volume>
<fpage>807</fpage>&#x02013;<lpage>819</lpage>. <pub-id pub-id-type="doi">10.1113/expphysiol.2006.033506</pub-id>
<?supplied-pmid 16857720?><pub-id pub-id-type="pmid">16857720</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irodova</surname><given-names>N. L.</given-names></name><name><surname>Lankin</surname><given-names>V. Z.</given-names></name><name><surname>Konovalova</surname><given-names>G. K.</given-names></name><name><surname>Kochetov</surname><given-names>A. G.</given-names></name><name><surname>Chazova</surname><given-names>I. E.</given-names></name></person-group> (<year>2002</year>). <article-title>Oxidative stress in patients with primary pulmonary hypertension.</article-title>
<source><italic>Bull. Exp. Biol. Med.</italic></source>
<volume>133</volume>
<fpage>580</fpage>&#x02013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1023/A:1020238026534</pub-id><pub-id pub-id-type="pmid">12447471</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jefferson</surname><given-names>J. A.</given-names></name><name><surname>Simoni</surname><given-names>J.</given-names></name><name><surname>Escudero</surname><given-names>E.</given-names></name><name><surname>Hurtado</surname><given-names>M. E.</given-names></name><name><surname>Swenson</surname><given-names>E. R.</given-names></name><name><surname>Wesson</surname><given-names>D. E.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Increased oxidative stress following acute and chronic high altitude exposure.</article-title>
<source><italic>High Alt. Med. Biol.</italic></source>
<volume>5</volume>
<fpage>61</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1089/152702904322963690</pub-id>
<?supplied-pmid 15072717?><pub-id pub-id-type="pmid">15072717</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>K. S.</given-names></name><name><surname>Micco</surname><given-names>A. J.</given-names></name><name><surname>Czartolomna</surname><given-names>J.</given-names></name><name><surname>Latham</surname><given-names>L.</given-names></name><name><surname>Voelkel</surname><given-names>N. F.</given-names></name></person-group> (<year>1992</year>). <article-title>Rapid onset of hypoxic vasoconstriction in isolated lungs.</article-title>
<source><italic>J. Appl. Physiol.</italic></source> (<year>1985</year>) <volume>72</volume>
<fpage>2018</fpage>&#x02013;<lpage>2023</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1992.72.5.2018</pub-id>
<?supplied-pmid 1601813?><pub-id pub-id-type="pmid">1601813</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karamsetty</surname><given-names>M. R.</given-names></name><name><surname>Klinger</surname><given-names>J. R.</given-names></name><name><surname>Hill</surname><given-names>N. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Evidence for the role of p38 MAP kinase in hypoxia-induced pulmonary vasoconstriction.</article-title>
<source><italic>Am. J. Physiol. Lung Cell. Mol. Physiol.</italic></source>
<volume>283</volume>
<fpage>L859</fpage>&#x02013;<lpage>L866</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00475.2001</pub-id>
<?supplied-pmid 12225963?><pub-id pub-id-type="pmid">12225963</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>M.</given-names></name><name><surname>Staub</surname><given-names>N. C.</given-names></name></person-group> (<year>1966</year>). <article-title>Response of small pulmonary arteries to unilobar hypoxia and hypercapnia.</article-title>
<source><italic>Circ. Res.</italic></source>
<volume>19</volume>
<fpage>426</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.19.2.426</pub-id><pub-id pub-id-type="pmid">5914855</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishimoto</surname><given-names>Y.</given-names></name><name><surname>Kato</surname><given-names>T.</given-names></name><name><surname>Ito</surname><given-names>M.</given-names></name><name><surname>Azuma</surname><given-names>Y.</given-names></name><name><surname>Fukasawa</surname><given-names>Y.</given-names></name><name><surname>Ohno</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects.</article-title>
<source><italic>J. Thorac. Cardiovasc. Surg.</italic></source>
<volume>150</volume>
<fpage>645</fpage>&#x02013;<lpage>654</lpage>.e3. <pub-id pub-id-type="doi">10.1016/j.jtcvs.2015.05.052</pub-id>
<?supplied-pmid 26095621?><pub-id pub-id-type="pmid">26095621</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leblanc</surname><given-names>A. J.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Dougherty</surname><given-names>P. J.</given-names></name><name><surname>Reyes</surname><given-names>R. A.</given-names></name><name><surname>Shipley</surname><given-names>R. D.</given-names></name><name><surname>Korzick</surname><given-names>D. H.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Divergent effects of aging and sex on vasoconstriction to endothelin in coronary arterioles.</article-title>
<source><italic>Microcirculation</italic></source>
<volume>20</volume>
<fpage>365</fpage>&#x02013;<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1111/micc.12028</pub-id>
<?supplied-pmid 23198990?><pub-id pub-id-type="pmid">23198990</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le&#x000f3;n-Velarde</surname><given-names>F.</given-names></name><name><surname>Maggiorini</surname><given-names>M.</given-names></name><name><surname>Reeves</surname><given-names>J. T.</given-names></name><name><surname>Aldashev</surname><given-names>A.</given-names></name><name><surname>Asmus</surname><given-names>I.</given-names></name><name><surname>Bernardi</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Consensus statement on chronic and subacute high altitude diseases.</article-title>
<source><italic>High Alt. Med. Biol.</italic></source>
<volume>6</volume>
<fpage>147</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2005.6.147</pub-id>
<?supplied-pmid 16060849?><pub-id pub-id-type="pmid">16060849</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le&#x000f3;n-Velarde</surname><given-names>F.</given-names></name><name><surname>Villafuerte</surname><given-names>F. C.</given-names></name><name><surname>Richalet</surname><given-names>J. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Chronic mountain sickness and the heart.</article-title>
<source><italic>Prog. Cardiovasc. Dis.</italic></source>
<volume>52</volume>
<fpage>540</fpage>&#x02013;<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcad.2010.02.012</pub-id>
<?supplied-pmid 20417348?><pub-id pub-id-type="pmid">20417348</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Tsai</surname><given-names>P.</given-names></name><name><surname>Wieder</surname><given-names>E. D.</given-names></name><name><surname>Kribben</surname><given-names>A.</given-names></name><name><surname>Van Putten</surname><given-names>V.</given-names></name><name><surname>Schrier</surname><given-names>R. W.</given-names></name><etal/></person-group> (<year>1994</year>). <article-title>Vascular smooth muscle cells grown on Matrigel. A model of the contractile phenotype with decreased activation of mitogen-activated protein kinase.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>269</volume>
<fpage>19653</fpage>&#x02013;<lpage>19658</lpage>. <?supplied-pmid 8034734?><pub-id pub-id-type="pmid">8034734</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q. H.</given-names></name><name><surname>Zheng</surname><given-names>Y. M.</given-names></name><name><surname>Wang</surname><given-names>Y. X.</given-names></name></person-group> (<year>2007</year>). <article-title>Two distinct signaling pathways for regulation of spontaneous local Ca2 + release by phospholipase C in airway smooth muscle cells.</article-title>
<source><italic>Pflugers Arch.</italic></source>
<volume>453</volume>
<fpage>531</fpage>&#x02013;<lpage>541</lpage>. <?supplied-pmid 17093969?><pub-id pub-id-type="pmid">17093969</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loscalzo</surname><given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>Inducible NO synthesis in the vasculature: molecular context defines physiological response.</article-title>
<source><italic>Arterioscler. Thromb. Vasc. Biol.</italic></source>
<volume>21</volume>
<fpage>1259</fpage>&#x02013;<lpage>1260</lpage>. <?supplied-pmid 11498449?><pub-id pub-id-type="pmid">11498449</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000fc;neburg</surname><given-names>N.</given-names></name><name><surname>Siques</surname><given-names>P.</given-names></name><name><surname>Brito</surname><given-names>J.</given-names></name><name><surname>Arriaza</surname><given-names>K.</given-names></name><name><surname>Pena</surname><given-names>E.</given-names></name><name><surname>Klose</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Long-term chronic intermittent hypobaric hypoxia in rats causes an imbalance in the asymmetric dimethylarginine/nitric oxide pathway and ROS activity: a possible synergistic mechanism for altitude pulmonary hypertension?</article-title>
<source><italic>Pulm. Med.</italic></source>
<volume>2016</volume>:<issue>6578578</issue>. <pub-id pub-id-type="doi">10.1155/2016/6578578</pub-id>
<?supplied-pmid 27313889?><pub-id pub-id-type="pmid">27313889</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000fc;neburg</surname><given-names>N.</given-names></name><name><surname>Siques</surname><given-names>P.</given-names></name><name><surname>Brito</surname><given-names>J.</given-names></name><name><surname>De La Cruz</surname><given-names>J. J.</given-names></name><name><surname>Le&#x000f3;n-Velarde</surname><given-names>F.</given-names></name><name><surname>Hannemann</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Long-term intermittent exposure to high altitude elevates asymmetric dimethylarginine in first exposed young adults.</article-title>
<source><italic>High Alt. Med. Biol.</italic></source>
<volume>18</volume>
<fpage>226</fpage>&#x02013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2016.0123</pub-id>
<?supplied-pmid 28453332?><pub-id pub-id-type="pmid">28453332</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madden</surname><given-names>J. A.</given-names></name><name><surname>Vadula</surname><given-names>M. S.</given-names></name><name><surname>Kurup</surname><given-names>V. P.</given-names></name></person-group> (<year>1992</year>). <article-title>Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells.</article-title>
<source><italic>Am. J. Physiol.</italic></source>
<volume>263</volume>
<fpage>L384</fpage>&#x02013;<lpage>L393</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.1992.263.3.L384</pub-id>
<?supplied-pmid 1415563?><pub-id pub-id-type="pmid">1415563</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martyn</surname><given-names>K. D.</given-names></name><name><surname>Frederick</surname><given-names>L. M.</given-names></name><name><surname>von Loehneysen</surname><given-names>K.</given-names></name><name><surname>Dinauer</surname><given-names>M. C.</given-names></name><name><surname>Knaus</surname><given-names>U. G.</given-names></name></person-group> (<year>2006</year>). <article-title>Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases.</article-title>
<source><italic>Cell. Signal.</italic></source>
<volume>18</volume>
<fpage>69</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2005.03.023</pub-id>
<?supplied-pmid 15927447?><pub-id pub-id-type="pmid">15927447</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyrick</surname><given-names>B.</given-names></name><name><surname>Reid</surname><given-names>L.</given-names></name></person-group> (<year>1979</year>). <article-title>Hypoxia and incorporation of 3H-thymidine by cells of the rat pulmonary arteries and alveolar wall.</article-title>
<source><italic>Am. J. Pathol.</italic></source>
<volume>96</volume>
<fpage>51</fpage>&#x02013;<lpage>70</lpage>. <?supplied-pmid 464026?><pub-id pub-id-type="pmid">464026</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millatt</surname><given-names>L. J.</given-names></name><name><surname>Whitley</surname><given-names>G. S.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Leiper</surname><given-names>J. M.</given-names></name><name><surname>Siragy</surname><given-names>H. M.</given-names></name><name><surname>Carey</surname><given-names>R. M.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.</article-title>
<source><italic>Circulation</italic></source>
<volume>108</volume>
<fpage>1493</fpage>&#x02013;<lpage>1498</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000089087.25930.FF</pub-id>
<?supplied-pmid 12952847?><pub-id pub-id-type="pmid">12952847</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname><given-names>M.</given-names></name><name><surname>Gu</surname><given-names>X. Q.</given-names></name><name><surname>Pak</surname><given-names>O.</given-names></name><name><surname>Pamenter</surname><given-names>M. E.</given-names></name><name><surname>Haag</surname><given-names>D.</given-names></name><name><surname>Fuchs</surname><given-names>D. B.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species.</article-title>
<source><italic>Free Radic. Biol. Med.</italic></source>
<volume>52</volume>
<fpage>1033</fpage>&#x02013;<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.12.004</pub-id>
<?supplied-pmid 22222468?><pub-id pub-id-type="pmid">22222468</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname><given-names>M.</given-names></name><name><surname>Roth</surname><given-names>M.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>P.</given-names></name><name><surname>Hofmann</surname><given-names>S.</given-names></name><name><surname>Dony</surname><given-names>E.</given-names></name><name><surname>Goyal</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature.</article-title>
<source><italic>Circ. Res.</italic></source>
<volume>101</volume>
<fpage>258</fpage>&#x02013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.148015</pub-id>
<?supplied-pmid 17585072?><pub-id pub-id-type="pmid">17585072</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montezano</surname><given-names>A. C.</given-names></name><name><surname>Touyz</surname><given-names>R. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular mechanisms of hypertension&#x02014;reactive oxygen species and antioxidants: a basic science update for the clinician.</article-title>
<source><italic>Can. J. Cardiol.</italic></source>
<volume>28</volume>
<fpage>288</fpage>&#x02013;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1016/j.cjca.2012.01.017</pub-id>
<?supplied-pmid 22445098?><pub-id pub-id-type="pmid">22445098</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>L. G.</given-names></name></person-group> (<year>2001</year>). <article-title>Human genetic adaptation to high altitude.</article-title>
<source><italic>High Alt. Med. Biol.</italic></source>
<volume>2</volume>
<fpage>257</fpage>&#x02013;<lpage>279</lpage>.<pub-id pub-id-type="pmid">11443005</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moudgil</surname><given-names>R.</given-names></name><name><surname>Michelakis</surname><given-names>E. D.</given-names></name><name><surname>Archer</surname><given-names>S. L.</given-names></name></person-group> (<year>2005</year>). <article-title>Hypoxic pulmonary vasoconstriction.</article-title>
<source><italic>J. Appl. Physiol.</italic></source>
<volume>98</volume>
<fpage>390</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00733.2004</pub-id>
<?supplied-pmid 15591309?><pub-id pub-id-type="pmid">15591309</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niermeyer</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Shanmina</surname><given-names>Drolkar</given-names></name><name><surname>Zhuang</surname><given-names>J.</given-names></name><name><surname>Moore</surname><given-names>L. G.</given-names></name></person-group> (<year>1995</year>). <article-title>Arterial oxygen saturation in Tibetan and Han Infants Born in Lhasa, Tibet.</article-title>
<source><italic>N. Engl. J. Med.</italic></source>
<volume>333</volume>
<fpage>1248</fpage>&#x02013;<lpage>1252</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199511093331903</pub-id>
<?supplied-pmid 7566001?><pub-id pub-id-type="pmid">7566001</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nisbet</surname><given-names>R. E.</given-names></name><name><surname>Graves</surname><given-names>A. S.</given-names></name><name><surname>Kleinhenz</surname><given-names>D. J.</given-names></name><name><surname>Rupnow</surname><given-names>H. L.</given-names></name><name><surname>Reed</surname><given-names>A. L.</given-names></name><name><surname>Fan</surname><given-names>T. H.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice.</article-title>
<source><italic>Am. J. Respir. Cell. Mol. Biol.</italic></source>
<volume>40</volume>
<fpage>601</fpage>&#x02013;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1165/2008-0145OC</pub-id>
<?supplied-pmid 18952568?><pub-id pub-id-type="pmid">18952568</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pak</surname><given-names>O.</given-names></name><name><surname>Aldashev</surname><given-names>A.</given-names></name><name><surname>Welsh</surname><given-names>D.</given-names></name><name><surname>Peacock</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>The effects of hypoxia on the cells of the pulmonary vasculature.</article-title>
<source><italic>Eur. Respir. J.</italic></source>
<volume>30</volume>
<fpage>364</fpage>&#x02013;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.00128706</pub-id>
<?supplied-pmid 17666559?><pub-id pub-id-type="pmid">17666559</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penaloza</surname><given-names>D.</given-names></name><name><surname>Arias-Stella</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness.</article-title>
<source><italic>Circulation</italic></source>
<volume>115</volume>
<fpage>1132</fpage>&#x02013;<lpage>1146</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.624544</pub-id>
<?supplied-pmid 17339571?><pub-id pub-id-type="pmid">17339571</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pe&#x000f1;aloza</surname><given-names>D.</given-names></name><name><surname>Sime</surname><given-names>F.</given-names></name><name><surname>Ruiz</surname><given-names>L.</given-names></name></person-group> (<year>1971</year>). <article-title>&#x0201c;Cor pulmonale in chronic mountain sickness: present concept of Monge&#x02019;s disease,&#x0201d; in</article-title>
<source><italic>Ciba Foundation Symposium - High Altitude Physiology: Cardiac and Respiratory Aspects</italic></source>, <role>eds</role>
<person-group person-group-type="editor"><name><surname>Porter</surname><given-names>R.</given-names></name><name><surname>Knight</surname><given-names>J.</given-names></name></person-group> (<publisher-loc>Edinburgh</publisher-loc>: <publisher-name>Churchill Livingstone</publisher-name>), <fpage>41</fpage>&#x02013;<lpage>60</lpage>.</mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>J. M.</given-names></name><name><surname>Hume</surname><given-names>J. R.</given-names></name><name><surname>Archer</surname><given-names>S. L.</given-names></name><name><surname>Weir</surname><given-names>E. K.</given-names></name></person-group> (<year>1992</year>). <article-title>Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction.</article-title>
<source><italic>Am. J. Physiol.</italic></source>
<volume>262</volume>
<fpage>C882</fpage>&#x02013;<lpage>C890</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.1992.262.4.C882</pub-id>
<?supplied-pmid 1566816?><pub-id pub-id-type="pmid">1566816</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radi</surname><given-names>R.</given-names></name><name><surname>Beckman</surname><given-names>J. S.</given-names></name><name><surname>Bush</surname><given-names>K. M.</given-names></name><name><surname>Freeman</surname><given-names>B. A.</given-names></name></person-group> (<year>1991</year>). <article-title>Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide.</article-title>
<source><italic>Arch. Biochem. Biophys.</italic></source>
<volume>288</volume>
<fpage>481</fpage>&#x02013;<lpage>487</lpage>. <?supplied-pmid 1654835?><pub-id pub-id-type="pmid">1654835</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richalet</surname><given-names>J. P.</given-names></name><name><surname>Donoso</surname><given-names>M. V.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>D.</given-names></name><name><surname>Antezana</surname><given-names>A. M.</given-names></name><name><surname>Hudson</surname><given-names>C.</given-names></name><name><surname>Cort&#x000e8;s</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Chilean miners commuting from sea level to 4500 m: a prospective study.</article-title>
<source><italic>High Alt. Med. Biol.</italic></source>
<volume>3</volume>
<fpage>159</fpage>&#x02013;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1089/15270290260131894</pub-id>
<?supplied-pmid 12162860?><pub-id pub-id-type="pmid">12162860</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimoldi</surname><given-names>S. F.</given-names></name><name><surname>Rexhaj</surname><given-names>E.</given-names></name><name><surname>Pratali</surname><given-names>L.</given-names></name><name><surname>Bailey</surname><given-names>D. M.</given-names></name><name><surname>Hutter</surname><given-names>D.</given-names></name><name><surname>Faita</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Systemic vascular dysfunction in patients with chronic mountain sickness.</article-title>
<source><italic>Chest</italic></source>
<volume>141</volume>
<fpage>139</fpage>&#x02013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1378/chest.11-0342</pub-id>
<?supplied-pmid 21700688?><pub-id pub-id-type="pmid">21700688</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>M. J.</given-names></name><name><surname>Cobb</surname><given-names>M. H.</given-names></name></person-group> (<year>1997</year>). <article-title>Mitogen-activated protein kinase pathways.</article-title>
<source><italic>Curr. Opin. Cell Biol.</italic></source>
<volume>9</volume>
<fpage>180</fpage>&#x02013;<lpage>186</lpage>.<pub-id pub-id-type="pmid">9069255</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sartore</surname><given-names>S.</given-names></name><name><surname>Chiavegato</surname><given-names>A.</given-names></name><name><surname>Faggin</surname><given-names>E.</given-names></name><name><surname>Franch</surname><given-names>R.</given-names></name><name><surname>Puato</surname><given-names>M.</given-names></name><name><surname>Ausoni</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant.</article-title>
<source><italic>Circ. Res.</italic></source>
<volume>89</volume>
<fpage>1111</fpage>&#x02013;<lpage>1121</lpage>. <pub-id pub-id-type="doi">10.1161/hh2401.100844</pub-id>
<?supplied-pmid 11739275?><pub-id pub-id-type="pmid">11739275</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savourey</surname><given-names>G.</given-names></name><name><surname>Launay</surname><given-names>J. C.</given-names></name><name><surname>Besnard</surname><given-names>Y.</given-names></name><name><surname>Guinet</surname><given-names>A.</given-names></name><name><surname>Travers</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Normo- and hypobaric hypoxia: are there any physiological differences?</article-title>
<source><italic>Eur. J. Appl. Physiol.</italic></source>
<volume>89</volume>
<fpage>122</fpage>&#x02013;<lpage>126</lpage>. <?supplied-pmid 12665974?><pub-id pub-id-type="pmid">12665974</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherrer</surname><given-names>U.</given-names></name><name><surname>Allemann</surname><given-names>Y.</given-names></name><name><surname>Rexhaj</surname><given-names>E.</given-names></name><name><surname>Rimoldi</surname><given-names>S. F.</given-names></name><name><surname>Sartori</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Mechanisms and drug therapy of pulmonary hypertension at high altitude.</article-title>
<source><italic>High Alt. Med. Biol.</italic></source>
<volume>14</volume>
<fpage>126</fpage>&#x02013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2013.1006</pub-id>
<?supplied-pmid 23795732?><pub-id pub-id-type="pmid">23795732</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schr&#x000f6;der</surname><given-names>K.</given-names></name><name><surname>Kohnen</surname><given-names>A.</given-names></name><name><surname>Aicher</surname><given-names>A.</given-names></name><name><surname>Liehn</surname><given-names>E. A.</given-names></name><name><surname>B&#x000fc;chse</surname><given-names>T.</given-names></name><name><surname>Stein</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>NADPH oxidase NOX2 is required for hypoxia-induced mobilization of endothelial progenitor cells.</article-title>
<source><italic>Circ. Res.</italic></source>
<volume>105</volume>
<fpage>537</fpage>&#x02013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.205138</pub-id>
<?supplied-pmid 19679834?><pub-id pub-id-type="pmid">19679834</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schr&#x000f6;der</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Benkhoff</surname><given-names>S.</given-names></name><name><surname>Mieth</surname><given-names>A.</given-names></name><name><surname>Pliquett</surname><given-names>R.</given-names></name><name><surname>Kosowski</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>NOX4 is a protective reactive oxygen species generating vascular NADPH oxidase.</article-title>
<source><italic>Circ. Res.</italic></source>
<volume>110</volume>
<fpage>1217</fpage>&#x02013;<lpage>1225</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.267054</pub-id>
<?supplied-pmid 22456182?><pub-id pub-id-type="pmid">22456182</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacker</surname><given-names>P. T.</given-names></name></person-group> (<year>2011</year>). <article-title>SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF.</article-title>
<source><italic>Cancer Cell</italic></source>
<volume>19</volume>
<fpage>299</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2011.03.001</pub-id>
<?supplied-pmid 21397853?><pub-id pub-id-type="pmid">21397853</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seko</surname><given-names>Y.</given-names></name><name><surname>Tobe</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Kaburagi</surname><given-names>Y.</given-names></name><name><surname>Kadowaki</surname><given-names>T.</given-names></name><name><surname>Yazaki</surname><given-names>Y.</given-names></name></person-group> (<year>1996</year>). <article-title>Hypoxia and hypoxia/reoxygenation activate src family tyrosine kinases and p21ras in cultured rat cardiac myocytes.</article-title>
<source><italic>Biochem. Biophys. Res. Commun.</italic></source>
<volume>226</volume>
<fpage>530</fpage>&#x02013;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1996.1389</pub-id>
<?supplied-pmid 8806668?><pub-id pub-id-type="pmid">8806668</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serrander</surname><given-names>L.</given-names></name><name><surname>Cartier</surname><given-names>L.</given-names></name><name><surname>Bedard</surname><given-names>K.</given-names></name><name><surname>Banfi</surname><given-names>B.</given-names></name><name><surname>Lardy</surname><given-names>B.</given-names></name><name><surname>Plastre</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation.</article-title>
<source><italic>Biochem. J.</italic></source>
<volume>406</volume>
<fpage>105</fpage>&#x02013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20061903</pub-id>
<?supplied-pmid 17501721?><pub-id pub-id-type="pmid">17501721</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sgarbi</surname><given-names>G.</given-names></name><name><surname>Gorini</surname><given-names>G.</given-names></name><name><surname>Costanzini</surname><given-names>A.</given-names></name><name><surname>Barbato</surname><given-names>S.</given-names></name><name><surname>Solaini</surname><given-names>G.</given-names></name><name><surname>Baracca</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Hypoxia decreases ROS level in human fibroblasts.</article-title>
<source><italic>Int. J. Biochem. Cell Biol.</italic></source>
<volume>88</volume>
<fpage>133</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2017.05.005</pub-id>
<?supplied-pmid 28483665?><pub-id pub-id-type="pmid">28483665</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigaud</surname><given-names>S.</given-names></name><name><surname>Evelson</surname><given-names>P.</given-names></name><name><surname>Gonz&#x000e1;lez-Flecha</surname><given-names>B.</given-names></name></person-group> (<year>2005</year>). <article-title>H2O2-induced proliferation of primary alveolar epithelial cells is mediated by MAP kinases.</article-title>
<source><italic>Antioxid. Redox Signal.</italic></source>
<volume>7</volume>
<fpage>6</fpage>&#x02013;<lpage>13</lpage>. <?supplied-pmid 15650391?><pub-id pub-id-type="pmid">15650391</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonson</surname><given-names>T. S.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Huff</surname><given-names>C. D.</given-names></name><name><surname>Yun</surname><given-names>H.</given-names></name><name><surname>Qin</surname><given-names>G.</given-names></name><name><surname>Witherspoon</surname><given-names>D. J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Genetic evidence for high-altitude adaptation in Tibet.</article-title>
<source><italic>Science</italic></source>
<volume>329</volume>
<fpage>72</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1126/science.1189406</pub-id>
<?supplied-pmid 20466884?><pub-id pub-id-type="pmid">20466884</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siques</surname><given-names>P.</given-names></name><name><surname>L&#x000f3;pez de Pablo</surname><given-names>A. L.</given-names></name><name><surname>Brito</surname><given-names>J.</given-names></name><name><surname>Arribas</surname><given-names>S. M.</given-names></name><name><surname>Flores</surname><given-names>K.</given-names></name><name><surname>Arriaza</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Nitric oxide and superoxide anion balance in rats exposed to chronic and long term intermittent hypoxia.</article-title>
<source><italic>Biomed. Res. Int.</italic></source>
<volume>2014</volume>:<issue>610474</issue>. <pub-id pub-id-type="doi">10.1155/2014/610474</pub-id>
<?supplied-pmid 24719876?><pub-id pub-id-type="pmid">24719876</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staiculescu</surname><given-names>M. C.</given-names></name><name><surname>Foote</surname><given-names>C.</given-names></name><name><surname>Meininger</surname><given-names>G. A.</given-names></name><name><surname>Martinez-Lemus</surname><given-names>L. A.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of reactive oxygen species in microvascular remodeling.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>15</volume>
<fpage>23792</fpage>&#x02013;<lpage>23835</lpage>. <pub-id pub-id-type="doi">10.3390/ijms151223792</pub-id>
<?supplied-pmid 25535075?><pub-id pub-id-type="pmid">25535075</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenmark</surname><given-names>K. R.</given-names></name><name><surname>Gerasimovskaya</surname><given-names>E.</given-names></name><name><surname>Nemenoff</surname><given-names>R. A.</given-names></name><name><surname>Das</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Hypoxic activation of adventitial fibroblasts: role in vascular remodeling.</article-title>
<source><italic>Chest</italic></source>
<volume>122</volume>
<fpage>326S</fpage>&#x02013;<lpage>334S</lpage>. <pub-id pub-id-type="doi">10.1378/chest.122.6_suppl.326S</pub-id><pub-id pub-id-type="pmid">12475810</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenmark</surname><given-names>K. R.</given-names></name><name><surname>Mecham</surname><given-names>R. P.</given-names></name></person-group> (<year>1997</year>). <article-title>Cellular and molecular mechanisms of pulmonary vascular remodeling.</article-title>
<source><italic>Annu. Rev. Physiol.</italic></source>
<volume>59</volume>
<fpage>89</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.physiol.59.1.89</pub-id><pub-id pub-id-type="pmid">9074758</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sturrock</surname><given-names>A.</given-names></name><name><surname>Cahill</surname><given-names>B.</given-names></name><name><surname>Norman</surname><given-names>K.</given-names></name><name><surname>Huecksteadt</surname><given-names>T. P.</given-names></name><name><surname>Hill</surname><given-names>K.</given-names></name><name><surname>Sanders</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells.</article-title>
<source><italic>Am. J. Physiol. Lung Cell. Mol. Physiol.</italic></source>
<volume>290</volume>
<fpage>L661</fpage>&#x02013;<lpage>L673</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00269.2005</pub-id>
<?supplied-pmid 16227320?><pub-id pub-id-type="pmid">16227320</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Druhan</surname><given-names>L. J.</given-names></name><name><surname>Zweier</surname><given-names>J. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and superoxide production.</article-title>
<source><italic>Arch. Biochem. Biophys.</italic></source>
<volume>494</volume>
<fpage>130</fpage>&#x02013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2009.11.019</pub-id>
<?supplied-pmid 19932078?><pub-id pub-id-type="pmid">19932078</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sydow</surname><given-names>K.</given-names></name><name><surname>M&#x000fc;nzel</surname><given-names>T.</given-names></name></person-group> (<year>2003</year>). <article-title>ADMA and oxidative stress.</article-title>
<source><italic>Atheroscler. Suppl.</italic></source>
<volume>4</volume>
<fpage>41</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">14664902</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takac</surname><given-names>I.</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Lardy</surname><given-names>B.</given-names></name><name><surname>Anilkumar</surname><given-names>N.</given-names></name><name><surname>Lambeth</surname><given-names>J. D.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase NOX4.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>286</volume>
<fpage>13304</fpage>&#x02013;<lpage>13313</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.192138</pub-id>
<?supplied-pmid 21343298?><pub-id pub-id-type="pmid">21343298</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veith</surname><given-names>C.</given-names></name><name><surname>Kraut</surname><given-names>S.</given-names></name><name><surname>Wilhelm</surname><given-names>J.</given-names></name><name><surname>Sommer</surname><given-names>N.</given-names></name><name><surname>Quanz</surname><given-names>K.</given-names></name><name><surname>Seeger</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>NADPH oxidase 4 is not involved in hypoxia-induced pulmonary hypertension.</article-title>
<source><italic>Pulm. Circ.</italic></source>
<volume>6</volume>
<fpage>397</fpage>&#x02013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1086/687756</pub-id>
<?supplied-pmid 27683617?><pub-id pub-id-type="pmid">27683617</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visser</surname><given-names>M.</given-names></name><name><surname>Paulus</surname><given-names>W. J.</given-names></name><name><surname>Vermeulen</surname><given-names>M. A.</given-names></name><name><surname>Richir</surname><given-names>M. C.</given-names></name><name><surname>Davids</surname><given-names>M.</given-names></name><name><surname>Wisselink</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.</article-title>
<source><italic>Eur. J. Heart Fail.</italic></source>
<volume>12</volume>
<fpage>1274</fpage>&#x02013;<lpage>1281</lpage>. <pub-id pub-id-type="doi">10.1093/eurjhf/hfq158</pub-id>
<?supplied-pmid 20923854?><pub-id pub-id-type="pmid">20923854</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Von Euler</surname><given-names>U. S.</given-names></name><name><surname>Liljestrand</surname><given-names>G.</given-names></name></person-group> (<year>1946</year>). <article-title>Observations on the pulmonary arterial blood pressure in the cat.</article-title>
<source><italic>Acta Physiol. Scand.</italic></source>
<volume>12</volume>
<fpage>301</fpage>&#x02013;<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-1716.1946.tb00389.x</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Shimoda</surname><given-names>L. A.</given-names></name><name><surname>Sylvester</surname><given-names>J. T.</given-names></name></person-group> (<year>2004</year>). <article-title>Capacitative calcium entry and TRPC channel proteins are expressed in rat distal pulmonary arterial smooth muscle.</article-title>
<source><italic>Am. J. Physiol. Lung Cell. Mol. Physiol.</italic></source>
<volume>286</volume>
<fpage>L848</fpage>&#x02013;<lpage>L858</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00319.2003</pub-id>
<?supplied-pmid 14672922?><pub-id pub-id-type="pmid">14672922</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waypa</surname><given-names>G. B.</given-names></name><name><surname>Dudley</surname><given-names>V. J.</given-names></name><name><surname>Schumacker</surname><given-names>P. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of pulmonary arterial smooth muscle and endothelial mitochondrial complex III in chronic hypoxia-induced pulmonary hypertension.</article-title>
<source><italic>Am. J. Respir. Crit. Care Med.</italic></source>
<volume>193</volume>:<issue>A3884</issue>.</mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waypa</surname><given-names>G. B.</given-names></name><name><surname>Marks</surname><given-names>J. D.</given-names></name><name><surname>Mack</surname><given-names>M. M.</given-names></name><name><surname>Boriboun</surname><given-names>C.</given-names></name><name><surname>Mungai</surname><given-names>P. T.</given-names></name><name><surname>Schumacker</surname><given-names>P. T.</given-names></name></person-group> (<year>2002</year>). <article-title>Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes.</article-title>
<source><italic>Circ. Res.</italic></source>
<volume>91</volume>
<fpage>719</fpage>&#x02013;<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000036751.04896.F1</pub-id><pub-id pub-id-type="pmid">12386149</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wedgwood</surname><given-names>S.</given-names></name><name><surname>Dettman</surname><given-names>R. W.</given-names></name><name><surname>Black</surname><given-names>S. M.</given-names></name></person-group> (<year>2001</year>). <article-title>ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species.</article-title>
<source><italic>Am. J. Physiol. Lung Cell. Mol. Physiol.</italic></source>
<volume>281</volume>
<fpage>L1058</fpage>&#x02013;<lpage>L1067</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.2001.281.5.L1058</pub-id>
<?supplied-pmid 11597896?><pub-id pub-id-type="pmid">11597896</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weir</surname><given-names>E. K.</given-names></name><name><surname>Archer</surname><given-names>S. L.</given-names></name></person-group> (<year>1995</year>). <article-title>The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels.</article-title>
<source><italic>FASEB J.</italic></source>
<volume>9</volume>
<fpage>183</fpage>&#x02013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1096/fasebj.9.2.7781921</pub-id>
<?supplied-pmid 7781921?><pub-id pub-id-type="pmid">7781921</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissmann</surname><given-names>N.</given-names></name><name><surname>Zeller</surname><given-names>S.</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>R. U.</given-names></name><name><surname>Turowski</surname><given-names>C.</given-names></name><name><surname>Ay</surname><given-names>M.</given-names></name><name><surname>Quanz</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Impact of mitochondria and NADPH oxidases on acute and sustained hypoxic pulmonary vasoconstriction.</article-title>
<source><italic>Am. J. Respir. Cell. Mol. Biol.</italic></source>
<volume>34</volume>
<fpage>505</fpage>&#x02013;<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2005-0337OC</pub-id>
<?supplied-pmid 16357364?><pub-id pub-id-type="pmid">16357364</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>S. M.</given-names></name><name><surname>Holian</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells.</article-title>
<source><italic>Am. J. Respir. Cell. Mol. Biol.</italic></source>
<volume>36</volume>
<fpage>520</fpage>&#x02013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2006-0302SM</pub-id>
<?supplied-pmid 17158357?><pub-id pub-id-type="pmid">17158357</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welsh</surname><given-names>D. J.</given-names></name><name><surname>Peacock</surname><given-names>A. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Cellular responses to hypoxia in the pulmonary circulation.</article-title>
<source><italic>High Alt. Med Biol.</italic></source>
<volume>14</volume>
<fpage>111</fpage>&#x02013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2013.1016</pub-id>
<?supplied-pmid 23795730?><pub-id pub-id-type="pmid">23795730</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welsh</surname><given-names>D. J.</given-names></name><name><surname>Peacock</surname><given-names>A. J.</given-names></name><name><surname>MacLean</surname><given-names>M.</given-names></name><name><surname>Harnett</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Chronic hypoxia induces constitutive p38 mitogen-activated protein kinase activity that correlates with enhanced cellular proliferation in fibroblasts from rat pulmonary but not systemic arteries.</article-title>
<source><italic>Am. J. Respir. Crit. Care Med.</italic></source>
<volume>164</volume>
<fpage>282</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.164.2.2008054</pub-id>
<?supplied-pmid 11463602?><pub-id pub-id-type="pmid">11463602</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilcken</surname><given-names>D. E. L.</given-names></name><name><surname>Sim</surname><given-names>A. S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.</article-title>
<source><italic>Mol. Genet. Metab.</italic></source>
<volume>91</volume>
<fpage>309</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymgme.2007.04.017</pub-id>
<?supplied-pmid 17560156?><pub-id pub-id-type="pmid">17560156</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolin</surname><given-names>M. S.</given-names></name><name><surname>Gupte</surname><given-names>S. A.</given-names></name><name><surname>Neo</surname><given-names>B. H.</given-names></name><name><surname>Gao</surname><given-names>Q.</given-names></name><name><surname>Ahmad</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Oxidant-redox regulation of pulmonary vascular responses to hypoxia and nitric oxide-cGMP signaling.</article-title>
<source><italic>Cardiol. Rev.</italic></source>
<volume>18</volume>
<fpage>89</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1097/CRD.0b013e3181c9f088</pub-id>
<?supplied-pmid 20160535?><pub-id pub-id-type="pmid">20160535</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>B. W.</given-names></name><name><surname>Marsch</surname><given-names>E.</given-names></name><name><surname>Treps</surname><given-names>L.</given-names></name><name><surname>Baes</surname><given-names>M.</given-names></name><name><surname>Carmeliet</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>Endothelial cell metabolism in health and disease: impact of hypoxia.</article-title>
<source><italic>EMBO J.</italic></source>
<volume>36</volume>
<fpage>2187</fpage>&#x02013;<lpage>2203</lpage>. <pub-id pub-id-type="doi">10.15252/embj.201696150</pub-id>
<?supplied-pmid 28637793?><pub-id pub-id-type="pmid">28637793</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>C. M.</given-names></name><name><surname>Bansal</surname><given-names>G.</given-names></name><name><surname>Pavlickova</surname><given-names>L.</given-names></name><name><surname>Marcocci</surname><given-names>L.</given-names></name><name><surname>Suzuki</surname><given-names>Y. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Reactive oxygen species and antioxidants in pulmonary hypertension.</article-title>
<source><italic>Antioxid. Redox Signal.</italic></source>
<volume>18</volume>
<fpage>1789</fpage>&#x02013;<lpage>1796</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2012.4568</pub-id>
<?supplied-pmid 22657091?><pub-id pub-id-type="pmid">22657091</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>C. M.</given-names></name><name><surname>Cheema</surname><given-names>A. K.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Suzuki</surname><given-names>Y. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Protein carbonylation as a novel mechanism in redox signaling.</article-title>
<source><italic>Circ. Res.</italic></source>
<volume>102</volume>
<fpage>310</fpage>&#x02013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.159814</pub-id>
<?supplied-pmid 18079412?><pub-id pub-id-type="pmid">18079412</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Platoshyn</surname><given-names>O.</given-names></name><name><surname>Firth</surname><given-names>A. L.</given-names></name><name><surname>Yuan</surname><given-names>J. X. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Hypoxia divergently regulates production of reactive oxygen species in human pulmonary and coronary artery smooth muscle cells.</article-title>
<source><italic>Am. J. Physiol. Lung Cell. Mol. Physiol.</italic></source>
<volume>293</volume>
<fpage>L952</fpage>&#x02013;<lpage>L959</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00203.2007</pub-id>
<?supplied-pmid 17693484?><pub-id pub-id-type="pmid">17693484</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X. Q.</given-names></name><name><surname>Jing</surname><given-names>Z. C.</given-names></name></person-group> (<year>2009</year>). <article-title>High-altitude pulmonary hypertension.</article-title>
<source><italic>Eur. Respir. Rev.</italic></source>
<volume>18</volume>
<fpage>13</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1183/09059180.00011104</pub-id>
<?supplied-pmid 20956117?><pub-id pub-id-type="pmid">20956117</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Egashira</surname><given-names>N.</given-names></name><name><surname>Bando</surname><given-names>A.</given-names></name><name><surname>Nishime</surname><given-names>Y.</given-names></name><name><surname>Tonogai</surname><given-names>Y.</given-names></name><name><surname>Imuta</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Activation of p38 MAPK by oxidative stress underlying epirubicin-induced vascular endothelial cell injury.</article-title>
<source><italic>Free Radic. Biol. Med.</italic></source>
<volume>52</volume>
<fpage>1285</fpage>&#x02013;<lpage>1293</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.02.003</pub-id>
<?supplied-pmid 22330067?><pub-id pub-id-type="pmid">22330067</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>B.</given-names></name><name><surname>Meng</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Shi</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>NOX2 antisense attenuates hypoxia-induced oxidative stress and apoptosis in cardiomyocyte.</article-title>
<source><italic>Int. J. Med. Sci.</italic></source>
<volume>13</volume>
<fpage>646</fpage>&#x02013;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.7150/ijms.15177</pub-id>
<?supplied-pmid 27499697?><pub-id pub-id-type="pmid">27499697</pub-id></mixed-citation></ref></ref-list></back></article>